Quick Answer
Sonoma Pharmaceuticals, Inc. reported Total Revenue of $14.29 million for fiscal year 2025.
Sonoma Pharmaceuticals, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $14.29M | +12.2% |
| 2024 | $12.73M | -4.0% |
| 2023 | $13.27M | +5.1% |
| 2022 | $12.63M | -32.2% |
| 2021 | $18.63M | +3.9% |
| 2020 | $17.93M | -5.5% |
| 2019 | $18.97M | +13.9% |
| 2018 | $16.66M | +29.9% |
| 2017 | $12.82M | +36.9% |
| 2016 | $9.37M | -32.4% |
| 2015 | $13.85M | +1.4% |
| 2014 | $13.67M | -11.5% |
| 2013 | $15.45M | +21.2% |
| 2012 | $12.74M | +30.7% |
| 2011 | $9.75M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $4.35M | +22.0% | -22.4% |
| September 30, 2025 | $5.60M | +56.6% | +39.6% |
| June 30, 2025 | $4.01M | +18.4% | +12.7% |
| December 31, 2024 | $3.56M | +13.6% | -0.4% |
| September 30, 2024 | $3.58M | +31.1% | +5.5% |
| June 30, 2024 | $3.39M | -1.1% | +8.1% |
| December 31, 2023 | $3.14M | +6.6% | +14.9% |
| September 30, 2023 | $2.73M | -18.0% | -20.3% |
- Sonoma Pharmaceuticals, Inc. showed an increase of +12.2% in Total Revenue compared to the prior fiscal year.
- Over the 2011–2025 period, Sonoma Pharmaceuticals, Inc.’s total revenue has grown by 46.5% (from $9.75 million to $14.29 million).
- The most recent figure is from Sonoma Pharmaceuticals, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on June 17, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: